Cargando…

Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Kersten, Brigit E, den Broeder, Nathan, van den Hoogen, Frank H J, Knaapen-Hans, Hanneke A K, van den Ende, Cornelia H M, Vonk, Madelon C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Corrigenda
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310099/ https://www.ncbi.nlm.nih.gov/pubmed/32040189 http://dx.doi.org/10.1093/rheumatology/keaa047

Ejemplares similares

Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis
por: Kersten, Brigit E, et al.
Publicado: (2020)

Photoacoustic and high-frequency ultrasound imaging of systemic sclerosis patients
por: Daoudi, Khalid, et al.
Publicado: (2021)

Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
por: van den Hombergh, W. M. T., et al.
Publicado: (2018)

Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial
por: van den Hombergh, Wieneke M. T., et al.
Publicado: (2018)

Nailfold capillaroscopy and candidate-biomarker levels in systemic sclerosis-associated pulmonary hypertension: A cross-sectional study
por: Lemmers, Jacqueline MJ, et al.
Publicado: (2023)

Selexipag treatment in patients with systemic sclerosis–associated pulmonary arterial hypertension in clinical practice, a case series
por: Lemmers, Jacqueline MJ, et al.
Publicado: (2020)

Is there still a role for cyclophosphamide in the treatment of systemic sclerosis?
por: Vonk, Madelon C
Publicado: (2020)

What moves the rheumatologist? Unravelling decision making in the referral of systemic sclerosis patients to health professionals: a qualitative study
por: Stöcker, Juliane K, et al.
Publicado: (2018)

Room for improvement in non-pharmacological systemic sclerosis care? — a cross-sectional online survey of 650 patients
por: Stöcker, Juliane K., et al.
Publicado: (2020)

Opening the black box of non-pharmacological care in systemic sclerosis: a cross-sectional online survey of Dutch health professionals
por: Stöcker, Juliane K., et al.
Publicado: (2020)

Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis
por: Zwikker, Hanneke E, et al.
Publicado: (2014)

Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties
por: Lemmers, Jacqueline M.J., et al.
Publicado: (2022)

Evidence and consensus-based recommendations for non-pharmacological treatment of fatigue, hand function loss, Raynaud’s phenomenon and digital ulcers in patients with systemic sclerosis
por: Stöcker, Juliane K, et al.
Publicado: (2021)

Little Evidence for Usefulness of Biomarkers for Predicting Successful Dose Reduction or Discontinuation of a Biologic Agent in Rheumatoid Arthritis: A Systematic Review
por: Tweehuysen, Lieke, et al.
Publicado: (2017)

Corrigendum: Recent increases in Arctic freshwater flux affects Labrador Sea convection and Atlantic overturning circulation
por: Yang, Qian, et al.
Publicado: (2016)

Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis
por: Tweehuysen, Lieke, et al.
Publicado: (2018)

Unraveling SSc Pathophysiology; The Myofibroblast
por: van Caam, Arjan, et al.
Publicado: (2018)

(Dis)agreement of polymyalgia rheumatica relapse criteria, and prediction of relapse in a retrospective cohort
por: Bolhuis, Thomas E., et al.
Publicado: (2022)

Age-Related Health Hazards in Old Patients with First-Time Referral to a Rheumatologist: A Descriptive Study
por: van Lankveld, W., et al.
Publicado: (2011)

Corrigendum: Interleukin-12 bypasses common gamma-chain signalling in emergency natural killer cell lymphopoiesis
por: Ohs, Isabel, et al.
Publicado: (2017)

Economic Evaluation of the Dr. Bart Application in Individuals With Knee and/or Hip Osteoarthritis
por: Pelle, Tim, et al.
Publicado: (2022)

Digital vasculitis in a patient with rheumatoid arthritis: good response on anti-TNF blockade
por: van den Hoogen, F, et al.
Publicado: (2001)

Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology
por: Bhansing, Kavish J, et al.
Publicado: (2014)

Intersectoral Cooperation in 12 European Case Studies Aiming for Better Health, Environmental Sustainability, and Health Equity: Protocol for a Qualitative Evaluation
por: van der Vliet, Nina, et al.
Publicado: (2020)

High dose cyclophosphamide followed by autologous stem cell transplantation for the treatment of intractable rheumatoid arthritis (RA): a 2-year clinical and immunological follow-up
por: Verburg, RJ, et al.
Publicado: (2002)

Development and evaluation of a tailored e-self-management intervention (dr. Bart app) for knee and/or hip osteoarthritis: study protocol
por: Pelle, Tim, et al.
Publicado: (2019)

The Dutch Lower Extremity Functional Scale was highly reliable, valid and responsive in individuals with hip/knee osteoarthritis: a validation study
por: Hoogeboom, Thomas J, et al.
Publicado: (2012)

Requirements for systemic sclerosis expert centres in the Netherlands: A Delphi consensus study
por: Spierings, Julia, et al.
Publicado: (2020)

Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study
por: Michielsens, Celia A J, et al.
Publicado: (2021)

Corrigendum: Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer’s Disease
por: Kassaar, Omar, et al.
Publicado: (2017)

Abatacept and tocilizumab tapering in rheumatoid arthritis patients: results of SONATA—a retrospective, exploratory cohort study
por: Bouman, Chantal A M, et al.
Publicado: (2018)

Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial
por: den Broeder, Alfons A., et al.
Publicado: (2017)

Use and usability of the dr. Bart app and its relation with health care utilisation and clinical outcomes in people with knee and/or hip osteoarthritis
por: Pelle, Tim, et al.
Publicado: (2021)

Cross-Language Measurement Equivalence of the Center for Epidemiologic Studies Depression (CES-D) Scale in Systemic Sclerosis: A Comparison of Canadian and Dutch Patients
por: Kwakkenbos, Linda, et al.
Publicado: (2013)

Treatment of Epidemic Dropsy
Publicado: (1950)

Feasibility and potential effectiveness of a non-pharmacological multidisciplinary care programme for persons with generalised osteoarthritis: a randomised, multiple-baseline single-case study
por: Hoogeboom, Thomas J, et al.
Publicado: (2012)

Corrigendum: Antibiotic treatment at delivery shapes the initial oral microbiome in neonates
por: Gomez-Arango, Luisa F., et al.
Publicado: (2017)

Facilitators and barriers of intersectoral co-operation to promote healthier and more environmentally friendly behaviour: a qualitative evaluation through focus groups for the INHERIT project
por: van der Vliet, Nina, et al.
Publicado: (2022)

Psychosocial predictors of non-adherence to chronic medication: systematic review of longitudinal studies
por: Zwikker, Hanneke E, et al.
Publicado: (2014)

Corrigendum: Superfast assembly and synthesis of gold nanostructures using nanosecond low-temperature compression via magnetic pulsed power
por: Li, Binsong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tmdob8jfcsm59hmqs9akug55fd